Skip to main content
Cristina M. DeCesaris
( out of 46 reviews )

Cristina M. DeCesaris, MD

Languages spoken: English

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

Radiation Oncology
1950 Circle of Hope
Salt Lake City , UT 84112

Sugar House Health Center

1280 E. Stringham Avenue
Salt Lake City , UT 84106

Cristina DeCesaris, MD, a Huntsman Cancer Institute (HCI) physician, is a clinical track assistant professor in the Department of Radiation Oncology at the University of Utah. She is a member of the multidisciplinary Central Nervous System, Gynecology, and Pediatric teams.

Dr. DeCesaris’s clinical expertise is in delivering intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), image guided radiation therapy (IGRT), volumetric modulated arc therapy (VMAT), proton pencil-beam scanning (PBS) radiotherapy, and high dose rate (HDR) brachytherapy.

Dr. DeCesaris earned dual bachelor’s degrees in Neurobiology and Physiology as well as Psychology at The University of Maryland in College Park, MD. She went on to complete medical school at the Rutgers University’s Robert Wood Johnson School of Medicine and residency at the University of Maryland in Baltimore, MD. She is passionate about education, clinical research, and equitable delivery of healthcare. She is a member of many committees at the University of Utah. She is currently a member of many American Society for Radiation Oncology (ASTRO) and American Society of Clinical Oncology (ASCO), where she serves as a mentor training young physicians in critical review of medical literature. She is involved in prospective clinical trials and has completed clinical and database research.

Patient Rating

4.7 /5
( out of 46 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

Patient Comments

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

FARMINGTON HEALTH CENTER

My experience was with Dr Decesaris was very positive. She was thorough in her explanation of my radiation treatment and answered all my questions.

HUNTSMAN CANCER CENTER

Dr. Decesaris was very professional and I felt very comfortable with her knowledge of my problem.

HUNTSMAN CANCER CENTER

Dr Decesaris is above and beyond any doctor I've ever experienced. Her compassion, her thoughtfulness, her thoroughness, the time she takes to explain everything...she even apologizes if she's late!!! Who does that??? She does! I wish I could hand-pick her for every one of my acquaintances who will ever need to undergo radiation treatment.

FARMINGTON HEALTH CENTER

Dr. Decesaris answered my questions carefully and was open to discussing my feelings and any concerns I have. She showed empathy for what I was going through.

HUNTSMAN CANCER CENTER

Very kind. Very knowledgeable we felt a sense of trust.

HUNTSMAN CANCER CENTER

Doctor Decesaris is the best (not sure if I spelled her name right) but regardless ,she is wonderful. She even calls me out on issues that we don't agree on and I greatly appreciate that. The fact she is willing to fight for her patients and look out for their best interest. She is absolutely the best.

HUNTSMAN CANCER CENTER

She was very informative, knowledgeable, professional, and compassionate.

HUNTSMAN CANCER CENTER

She is an amazing physician.

HUNTSMAN CANCER CENTER

Dr. Decesaris is a straight shooter. Shows empathy but doesn't sugar-coat the situation or condescend.

Cristina DeCesaris, MD, a Huntsman Cancer Institute (HCI) physician, is a clinical track assistant professor in the Department of Radiation Oncology at the University of Utah. She is a member of the multidisciplinary Central Nervous System, Gynecology, and Pediatric teams.

Dr. DeCesaris’s clinical expertise is in delivering intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), image guided radiation therapy (IGRT), volumetric modulated arc therapy (VMAT), proton pencil-beam scanning (PBS) radiotherapy, and high dose rate (HDR) brachytherapy.

Dr. DeCesaris earned dual bachelor’s degrees in Neurobiology and Physiology as well as Psychology at The University of Maryland in College Park, MD. She went on to complete medical school at the Rutgers University’s Robert Wood Johnson School of Medicine and residency at the University of Maryland in Baltimore, MD. She is passionate about education, clinical research, and equitable delivery of healthcare. She is a member of many committees at the University of Utah. She is currently a member of many American Society for Radiation Oncology (ASTRO) and American Society of Clinical Oncology (ASCO), where she serves as a mentor training young physicians in critical review of medical literature. She is involved in prospective clinical trials and has completed clinical and database research.

Board Certification and Academic Information

Academic Departments Radiation Oncology -Assistant Professor (Clinical)

Education history

Undergraduate Psychology - University of Maryland B.S.
Undergraduate Neurobiology/Physiology - University of Maryland B.S.
Professional Medical Medicine - Rutgers Robert Wood Johnson Medical School M.D.
Fellowship Radiation Oncology - Perelman School of Medicine at the University of Pennsylvania Clinical Research Fellow
Internship Internal Medicine - Lankenau Medical Center Intern
Residency Radiation Oncology - University of Maryland Medical Center Resident
Chief Resident Radiation Oncology - University of Maryland Medical Center Chief Resident
Residency Radiation Oncology - University of Maryland Medical Center Resident
Professional Other ASCO Journals Editorial Fellow Fellow

Selected Publications

Journal Article

  1. DeCesaris CM, Rice SR, Bentzen SM, Jatczak J, Mishra MV, Nichols EM (2019). Quantification of Acute Skin Toxicities in Patients With Breast Cancer Undergoing Adjuvant Proton versus Photon Radiation Therapy: A Single Institutional Experience. Int J Radiat Oncol Biol Phys, 104(5), 1084-1090.
  2. Frick MA, Kao GD, Aguarin L, Chinniah C, Swisher-McClure S, Berman AT, Levin WP, Cengel KA, DeCesaris C, Hahn SM, Dorsey JF, Simone CB 2nd (2018). Circulating Tumor Cell Assessment in Presumed Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot Study. Int J Radiat Oncol Biol Phys, 102(3), 536-542.
  3. Poirier Y, Becker S, DeCesaris C, Culberson W, Draeger E, Gerry AJ, Johnstone CD, Gibbs A, Vujaskovic Z, Jackson IL (2020). The Impact of Radiation Energy on Dose Homogeneity and Organ Dose in the Göttingen Minipig Total-Body Irradiation Model. Radiat Res, 194(5), 544-556.
  4. Snider JW, Molitoris J, Shyu S, Diwanji T, Rice S, Kowalski E, DeCesaris C, Remick JS, Yi B, Zhang B, Hall A, Hanna N, Ng VY, Regine WF (2020). Spatially Fractionated Radiotherapy (GRID) Prior to Standard Neoadjuvant Conventionally Fractionated Radiotherapy for Bulky, High-Risk Soft Tissue and Osteosarcomas: Feasibility, Safety, and Promising Pathologic Response Rates. Radiat Res, 194(6), 707-714.
  5. Chinniah C, Aguarin L, Cheng P, DeCesaris C, Cutillo A, Berman AT, Frick M, Doucette A, Cengel KA, Levin W, Hahn S, Dorsey JF, Simone CB 2nd, Kao G (2019). Early Detection of Recurrence in Patients With Locally Advanced Non-Small-Cell Lung Cancer via Circulating Tumor Cell Analysis. Clinical lung cancer, 20(5), 384-390.e2.
  6. Moran BJ, Koroulakis A, DeCesaris C, Braccioforte MH, Amin N, Agarwal (2021). Long-term outcomes of a prospective randomized trial of 131Cs/125I permanent prostate brachytherapy. Brachytherapy, 20(1), 38-43.
  7. DeCesaris CM, McCarroll R, Mishra MV, Glass E, Greenwald BD, Carr S, Burrows W, Mehra R, Regine WF, Simone CB 2nd, Choi JI, Molitoris J (2020). Assessing Outcomes of Patients Treated With Re-Irradiation Utilizing Proton Pencil-Beam Scanning for Primary or Recurrent Malignancies of the Esophagus and Gastroesophageal Junction. Journal of thoracic oncology, 15(6), 1054-1064.
  8. Berman AT, DeCesaris CM, Simone CB 2nd, Vachani C, DiLullo G, Hampshire MK, Metz J, Hill-Kayser (2016). Use of Survivorship Care Plans and Analysis of Patient-Reported Outcomes in Multinational Patients With Lung Cancer. Journal of oncology practice, 12(5), e527-35.
  9. DeCesaris CM, Berger M, Choi JI, Carr SR, Burrows WM, Regine WF, Simone CB 2nd, Molitoris J (2020). Pathologic complete response (pCR) rates and outcomes after neoadjuvant chemoradiotherapy with proton or photon radiation for adenocarcinomas of the esophagus and gastroesophageal junction. Journal of gastrointestinal oncology, 11(4), 663-673.
  10. DeCesaris CM, Pollock A, Zhang B, Poirier Y, Kowalski E, Paulosky K, Mishra MV, Nichols (2021). Assessing the Need for Adjusted Organ-at-Risk Planning Goals for Patients Undergoing Adjuvant Radiation Therapy for Locally Advanced Breast Cancer with Proton Radiation. Practical radiation oncology, 11(2), 108-118.
  11. Zhu M, Kaiser A, Mishra MV, Kwok Y, Remick J, DeCesaris C, Langen K (2019). Multiple Computed Tomography Robust Optimization to Account for Random Anatomic Density Variations During Intensity Modulated Proton Therapy. Advances in radiation oncology, 5(5), 1022-1031.
  12. Koroulakis A, Rice SR, DeCesaris C, Knight N, Nichols E (2019). Perceptions and Patterns in Academic Publishing: A Survey of United States Residents in Radiation Oncology. Advances in radiation oncology, 5(2), 146-151.
  13. DeCesaris C, Rao A (2020). Characterizing the Risk of Vertebral Body Fractures in Patients Receiving Chemoradiotherapy for Esophageal Cancer. JAMA network open, 3(9), e2014340.
  14. Rock CB, Weil CR, Rock CB, Gravbrot N, Burt LM, DeCesaris C, Menacho ST, Jensen RL, Shrieve DC, Cannon D (2024). Patterns of failure after radiosurgery for WHO grade 1 or imaging defined meningiomas: Long-term outcomes and implications for management. Journal of clinical neuroscience, 120, 175-180.
  15. Gravbrot N, Rock CB, Weil CR, Rock CB, Burt LM, DeCesaris CM, Jensen RL, Shrieve DC, Cannon D (2024). Gross tumor and intracranial control benefits with fractionated radiotherapy compared to stereotactic radiosurgery for patients with WHO grade 2 meningioma. World neurosurgery,
  16. Gravbrot N, Weil CR, DeCesaris CM, Gaffney DK, Suneja G, Burt L (2024). Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer. European journal of cancer (Oxford, England, 201, 113913.
  17. Huang YJ, DeCesaris CM, Sarkar V, Zhao H, Kunz J, Nelson G, Li X, Suneja G, Burt LM, Gaffney D (2024). Image-guided preplanning workflow for high-dose-rate interstitial brachytherapy for gynecological malignancies. Brachytherapy, 23(1), 25-34.
  18. DeCesaris CM, Mossahebi S, Jatczak J, Rao AD, Zhu M, Mishra MV, Nichols (2021). Outcomes of and treatment planning considerations for a hybrid technique delivering proton pencil-beam scanning radiation to women with metal-containing tissue expanders undergoing post-mastectomy radiation. Radiotherapy and oncology, 164, 289-298.
  19. Lee SS, Weil CR, Boyd LR, DeCesaris C, Gaffney D, Suneja (2023). Trends in use of radiation therapy, chemotherapy, and combination chemoradiotherapy in advanced uterine cancer before, during, and after GOG 258. International journal of gynecological cancer, 33(9), 1408-1418.
  20. Weil CR, Rock CB, Sarkar V, Gravbrot N, Lew FH, Rock CB, Burt LM, DeCesaris CM, Jensen RL, Shrieve DC, Cannon D (2025). Lack of Impact of Expansion Size From Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Fractionated Radiotherapy for WHO Grade 1 Meningiomas. American journal of clinical oncology, 48(8), 403-409.
  21. Jhandi S, Jhandi AS, Cannon DM, Burt LM, DeCesaris C, Menacho ST, Colman H, Jensen R (2025). Stereotactic radiosurgery for radiation'induced meningiomas: long'term institutional outcomes with patient- and lesion'level analyses and an updated meta'analysis. Journal of neuro-oncology, 176(1), 122.
  22. DeCesaris C, Bedell S, Gaffney D, Suneja G, Burt L, Brower (2025). Identification and Management of Late Toxicities After Radiation Therapy for Vulvar Cancer. Practical radiation oncology,
  23. Cruttenden J, Weil C, Byer D, Burt L, Suneja G, Gaffney D, DeCesaris (2024). Patterns of Care in Adjuvant Radiation Therapy for Stage II Endometrioid Endometrial Adenocarcinoma: A National Cancer Database Analysis. Advances in radiation oncology, 10(2), 101698.
  24. DeCesaris C, Bedell S, Kelley K, Gaffney D, Suneja G, Burt L, Jarboe E, Brower (2025). Use of Radiation Therapy in the Management of Vulvar Cancers-Identification and Management of Acute and Late Toxicities. Practical radiation oncology, 15(1), e57-e62.
  25. DeCesaris C, Wilson T, Kim J, Burt L, Grant J, Harkenrider MM, Huang J, Jhingran A, Kidd E, Konski A, Lin L, Small W Jr, Suneja G, Gaffney (2024). Financial Improvements From Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared With Standard of Care, "SAVE" Trial. Practical radiation oncology, 14(6), e500-e506.

Review

  1. Burt L, Jarboe E, Gaffney D, Suneja G, DeCesaris C, Bedell S, Brower (2025). Vulvar Cancer: Histopathologic Considerations and Nuances to Management. Practical radiation oncology, 15(1), 86-92.

Case Report

  1. DeCesaris C, Amin NP, Hundal J, Vujaskovic Z, Agarwal (2018). Hyperthermia and Hyper-fractionated Radiation for a Cutaneous Squamous Cell Carcinoma Progressing on Standard Therapy: A Case Report. Advances in radiation oncology, 4(1), 4-9.

Letter

  1. DeCesaris C, Rice SR, Bentzen SM, Jatczak J, Mishra MV, Mossahebi S, Nichols EM (2019). In Reply to Tommasino et al. [Letter to the editor]. Int J Radiat Oncol Biol Phys, 105(3), 677-678.
  2. DeCesaris CM, Kokeny (2022). The Best Defense is a Good Offense. International journal of radiation oncology, biology, physics, 114(4), 574-575.
  3. Urias E, DeCesaris (2025). Comment on "A comparison of outcomes after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases: an international multi-center study". Journal of neuro-oncology, 175(3), 1469-1470.

Other

  1. Gravbrot N, Weil CR, DeCesaris CM, Gaffney DK, Suneja G, Burt L (2024). Corrigendum to "Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer" Eur. J. Cancer (201) (April) 2024, 113913. European journal of cancer (Oxford, England, 202, 114017.